| 000 | 01537 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513002420.0 | ||
| 264 | 0 | _c19810528 | |
| 008 | 198105s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00435411 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmyth, J F | |
| 245 | 0 | 0 |
_aThe clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1980 |
||
| 300 |
_a93-101 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdenosine Deaminase Inhibitors |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCoformycin _xadverse effects |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLeukemia, Lymphoid _xdrug therapy |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNucleoside Deaminases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPentostatin |
| 650 | 0 | 4 |
_aRibonucleosides _xtherapeutic use |
| 650 | 0 | 4 |
_aUric Acid _xblood |
| 700 | 1 | _aPaine, R M | |
| 700 | 1 | _aJackman, A L | |
| 700 | 1 | _aHarrap, K R | |
| 700 | 1 | _aChassin, M M | |
| 700 | 1 | _aAdamson, R H | |
| 700 | 1 | _aJohns, D G | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 5 _gno. 2 _gp. 93-101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00435411 _zAvailable from publisher's website |
| 999 |
_c6970305 _d6970305 |
||